Embracing Imperfection for Impact: The Bold Move to Measure Medical Impact

Medical Affairs has recently been challenged to earn and justify its position as the “third pillar” of the industry, a strategic partner that joins Commercial and R&D as critical decision-makers. To rise to this challenge—and to usher in a new era of Medical Affairs that defines value as impact at scale—it is essential that Medical Affairs demonstrate that said impact supports both business goals and societal needs.

Welcome initiatives have been undertaken to address this need. Join Danie du Plessis, Troels Sørensen, and Michael Shaw as they discuss the best practices and hurdles to implement tangible medical affairs impact measurement.

Learning Objectives

• – Implement Tangible Strategies: Explore actionable approaches and tactics to transform your organization’s Medical impact measurement process.
• – Appreciate the Need for a Paradigm Shift: Understand the evolving requirements for Medical Affairs to capture and communicate impact effectively.
• – Recognize Challenges in Medical Impact Measurement: Identify common barriers associated with measuring Medical impact.

Moderator:

Danie du Plessis

Executive VP Pharmaceutical Operations

Kyowa Kirin, Inc.

Panelist:

Troels Sørensen

Global Head Clinical Practice

Boehringer Ingelheim

Panelist:

Michael Shaw

Principal, Global Head – Compliance, Privacy & Risk

ZS Associates